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Introduction
During learning and memory, neurons undergo changes in ex-
citability to enhance their efficacy. One way to modulate neuro-
nal excitability is through regulating the number and composition 
of ion channels expressed on the cell membrane (Zhang and 
Linden, 2003; Kim and Hoffman, 2008). Such regulation can be 
achieved through controlling the local translation of dendritic 
mRNAs to provide a rapid response to neuronal activity and en-
sure proper temporal and spatial expression. Our previous work 
has shown that the local dendritic translation of an ion channel, 
Kv1.1, mRNA is repressed by mTORC1 kinase activity (Raab-
Graham et al., 2006).
Kv1.1 is a dendrotoxin-sensitive voltage-gated potassium 
channel that is phylogenetically related to the Shaker channel in 
Drosophila melanogaster (Tanouye and Ferrus, 1985; Hopkins 
et al., 1994). Kv1.1 is characterized as a delayed rectifier potassium 
channel that controls the frequency of the action potential (Brew 
et al., 2003). Unlike many ion channels that have redundant func-
tions, Kv1.1 is essential. Mice lacking Kv1.1 either die early or 
have frequent spontaneous seizures (Smart et al., 1998). Further-
more, haploid insufficiency leads to episodic ataxia, a human neu-
rological disease caused by mutations in Kv1.1 (Zerr et al., 1998). 
Although a dendrotoxin-sensitive Kv current has been described in 
CA1 pyramidal dendrites, the molecular identity of this current re-
mains inconclusive (Storm, 1988; Golding et al., 1999; Metz et al., 
2007; Chen and Johnston, 2010). Moreover, before our study 
describing N-methyl-d-aspartate receptor (NMDAR)/mTORC1 
(mammalian target of rapamycin [mTOR] complex 1)-mediated 
suppression of Kv1.1 local translation in dendrites, Kv1.1 was con-
sidered to be only expressed in axons of hippocampal neurons 
(Schechter, 1997; Southan and Owen, 1997; Geiger and Jonas, 
2000; Monaghan et al., 2001; Raab-Graham et al., 2006; Chen and 
Johnston, 2010). Here, we report the molecular mechanism for the 
regulation of dendritic Kv1.1 mRNA translation.
mTOR is a ubiquitous serine/threonine kinase that forms 
two unique complexes, mTORC1 and mTORC2 (mTOR com-
plex 2). mTORC1 kinase promotes cap-dependent translation 
via phosphorylation of S6K and 4E-BP, molecules critical for 
translational initiation. In neurons, mTORC1 kinase is activated 
by its upstream effectors, including neuronal receptors such as 
 Little is known about how a neuron undergoes site-specific changes in intrinsic excitability during neu-ronal activity. We provide evidence for a novel 
mechanism for mTORC1 kinase–dependent translational 
regulation of the voltage-gated potassium channel Kv1.1 
messenger RNA (mRNA). We identified a microRNA, 
miR-129, that repressed Kv1.1 mRNA translation when 
mTORC1 was active. When mTORC1 was inactive, 
we found that the RNA-binding protein, HuD, bound to 
Kv1.1 mRNA and promoted its translation. Unexpect-
edly, inhibition of mTORC1 activity did not alter levels of 
miR-129 and HuD to favor binding to Kv1.1 mRNA. 
However, reduced mTORC1 signaling caused the degra-
dation of high affinity HuD target mRNAs, freeing HuD to 
bind Kv1.1 mRNA. Hence, mTORC1 activity regulation 
of mRNA stability and high affinity HuD-target mRNA 
degradation mediates the bidirectional expression of 
dendritic Kv1.1 ion channels.
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bind Kv1.1 mRNA when mTORC1 kinase is active and inactive, 
respectively. Using a local translation assay, we determined that 
removal of the miR-129 site releases the mTORC1-dependent 
repression of Kv1.1 mRNA translation. Furthermore, we provide 
evidence suggesting that HuD high affinity mRNA targets, 
such as CaMKII, GAP-43, and Homer1a, are degraded when 
mTORC1 is inhibited, allowing HuD to switch targets and over-
come miR-129 repression of Kv1.1 mRNA.
Results
mTORC1 kinase activity does not affect 
Kv1.1 mRNA levels
Previously, we have shown that mTORC1 kinase activity in 
cortical and hippocampal neurons suppresses the local protein 
synthesis of Kv1.1 mRNA in neuronal dendrites (Raab-Graham 
et al., 2006). When mTORC1 kinase activity is inhibited by its 
specific inhibitor, rapamycin, a significant increase in dendritic 
Kv1.1 protein is observed (Fig. 1 A; Raab-Graham et al., 2006). 
To determine the molecular mechanism for the change in Kv1.1 
expression in dendrites, we first assessed whether there were 
corresponding changes in mRNA levels with mTORC1 activ-
ity. In cultured neurons (21–28 d in culture), mTORC1 kinase is 
phosphorylated and thus constitutively active (Fig. 1 A). Syn-
aptoneurosomal preparation was checked for purity by Western 
blot and immunostaining with a nuclear marker (Fig. S1 A). 
Treatment with rapamycin inhibits mTORC1 kinase activity by 
reducing the active p-mTOR over total mTOR ratio to 59.20 ± 
4.67% and leads to an approximately twofold increase in Kv1.1 
protein (Fig. 1 A, Kv1.1: DMSO [1.00 ± 0.18] and rapamycin 
[2.00 ± 0.26]; Raab-Graham et al., 2006). We next examined 
the mRNA levels in synaptoneurosomes (SNs) isolated from 
NMDARs through the signaling molecules phosphoinositide 
3-kinase, Akt, and Tsc1/2 (tuberous sclerosis complex proteins 1 
and 2; Klann and Dever, 2004; Raab-Graham et al., 2006; 
Costa-Mattioli et al., 2009). Electrophysiological studies have 
shown that mTORC1 kinase activity is required for long-term 
depression and late long-term potentiation (Volk et al., 2007; 
Ronesi and Huber, 2008; Hoeffer and Klann, 2010). These 
persistent changes in excitatory neurotransmission have been 
widely accepted as a model for the cellular basis for learning 
and memory (Bliss and Lomo, 1973).
Although mTORC1 kinase–dependent translational activa-
tion is well studied, how selective mRNAs undergo translational 
repression when mTORC1 kinase is active remains unclear. 
Translational repression can be achieved by mRNA-binding 
molecules such as miRNAs or RNA-binding proteins. miRNAs 
are 18–25-nt-long noncoding RNAs that bind to their target se-
quences in the 3 UTR of mRNAs, resulting in reduced protein 
expression via translational silencing or mRNA degradation 
(Kosik, 2006; Filipowicz et al., 2008; Bartel, 2009; Konecna 
et al., 2009).
How mRNA repression is relieved to mediate bidirec-
tional protein expression in an activity-dependent manner is an 
important question. It was first hypothesized that miRNAs 
could directly or indirectly affect RNA-binding proteins’ ability 
to interact with their mRNA targets (George and Tenenbaum, 
2006). Since then, a growing body of evidence suggests that 
RNA-binding proteins can displace miRNAs from their target 
mRNAs even when the binding sites are located many nucleo-
tides apart (Meisner and Filipowicz, 2011; Kundu et al., 2012; 
Srikantan et al., 2012; Xue et al., 2013).
Here, we report the identification of an miRNA, miR-129, 
and an RNA-binding protein, HuD, both of which reversibly 
Figure 1. mTORC1 kinase–dependent repres-
sion of Kv1.1 is not a result of mRNA stability. 
(A) SNs were isolated from DMSO- or rapa-
mycin-treated DIV 21 cortical neurons. Rep-
resentative Western blots and quantification 
indicate the relative level of p-mTOR/mTOR 
and Kv1.1/tubulin (loading control). ***, P < 
0.001; *, P< 0.05; unpaired Student’s t test. 
p-mTOR, n = 7; Kv1.1, n = 5 over two in-
dependent cultures. (B) SN RNA was isolated 
from DMSO- or rapamycin-treated cortical 
neurons, and Kv1.1 mRNA was detected via 
RT-qPCR. Representative DNA gel of RT-qPCR 
samples showing amplification of a specific 
Kv1.1 band. DMSO, n = 5; rapamycin, n = 6 
over three independent cultures. Error bars 
show SEMs.
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morphological similarity between neurons is demonstrated in 
Fig. S1 C; Blichenberg et al., 1999). The level of surface Kv1.1 
protein was determined by immunocytochemistry on nonperme-
abilized neurons using an antibody that recognizes the extracellu-
lar domain of Kv1.1 (Tiffany et al., 2000; Raab-Graham et al., 
2006). As expected, excess 3UTR containing the putative mTRS 
of Kv1.1 mRNA released endogenous Kv1.1 mRNA from re-
pression, resulting in an approximately fivefold (5.41 ± 0.99) in-
crease in Kv1.1 surface protein expression in the dendrites as 
determined by signal intensity of punctate structures with no sig-
nificant change in the soma (Fig. 2 and Fig. S1 D). Such an in-
crease is comparable to the levels observed when mTORC1 
kinase is inhibited by rapamycin, and excess mTRS does not fur-
ther increase Kv1.1 expression in rapamycin-treated neurons 
(Fig. 2). Collectively, these data suggest that the putative mTRS 
within the 3UTR is required for repressing Kv1.1 translation in 
an mTORC1 kinase–sensitive manner.
miR-129 binds Kv1.1 mRNA in an 
mTORC1 kinase–dependent manner
Notably, sequence alignment of the 3 UTR containing the 
mTRS with other mammalian Kv1.1 UTRs revealed a con-
served binding site (or seed match sequence) for the miRNA 
miR-129 (Fig. 3 A). Consistent with Kv1.1 mRNA levels re-
maining constant with changes in mTOR activity, the comple-
mentary of the miR-129 binding site to the 3UTR sequence is 
considered to be weak, favoring a role in translational repres-
sion over degradation (Filipowicz et al., 2008). To determine 
whether miR-129 binds to Kv1.1 mRNA and perhaps mediates 
the mTOR-dependent repression, we used an RNA affinity cap-
ture system (Kuwano et al., 2008). RNA was synthesized by in 
cortical neurons treated with rapamycin or carrier (DMSO) by 
real-time quantitative PCR (qPCR). The representative gel indi-
cates the amplification of a specific Kv1.1 product for each con-
dition (Fig. 1 B, top). Independent of mTORC1 kinase activity, 
the mRNA level remains constant (Fig. 1 B, bar graph), sug-
gesting a mechanism of altered translation rather than changes 
in mRNA transport or degradation.
Kv1.1 3UTR is required for mTORC1 
kinase–dependent translational repression
To investigate the molecular mechanism of such translational re-
pression, we first searched for potential regulatory sequences in 
Kv1.1 mRNA that confer mTORC1 kinase–sensitive repression 
(Raab-Graham et al., 2006). Previously, we showed local transla-
tion of Kv1.1 when mTORC1 kinase is inhibited by blocking 
NMDARs or by the mTORC1-specific inhibitor rapamycin using 
the construct containing the coding region (CR) plus the 230-nt 
3UTR of Kv1.1 cloned from synaptoneurosomal cDNA (Raab-
Graham et al., 2006). Based on this finding, we hypothesized that 
a putative mTORC1 kinase repression sequence (mTRS) was 
present within this 3UTR.
To verify the importance of the mTRS for Kv1.1 translation 
in neurons, we designed a competition assay in which excess 
3UTR was introduced to compete for the binding of factors that 
suppress endogenous Kv1.1, thus resulting in increased Kv1.1 
expression (Fig. S1 B). Exogenous 3UTR containing the puta-
tive mTRS was introduced into neurons by a Sindbis virus coding 
for the fluorescent protein Kaede (Ando et al., 2002) fused to the 
3UTR. To control for nonspecific effects caused by viral infec-
tion, neurons were infected with virus coding for Kaede fused 
to the dendritic targeting sequence (DTS) of MAP2 (Fig. 2; 
Figure 2. Overexpression of Kv1.1 3UTR removes endogenous repression factors, leading to increased Kv1.1 protein. (left) Representative neurons 
infected with Sindbis virus coding for control RNA (Kaede-MAP2-DTS) or Kv1.1 3UTR (DIV 21). Neurons were treated with DMSO or rapamycin. Arrow-
heads show Kv1.1 puncta (signal). Bar, 20 µm. (right) Quantification of surface expression of Kv1.1. ***, P < 0.001; *, P< 0.05; unpaired Student’s t test. 
Control + DMSO: n = 16 neurons, 21 dendrites; 3UTR + DMSO: n = 17 neurons, 20 dendrites; control + rapamycin (Rapa): n = 7 neurons, 8 dendrites; 
3UTR + rapamycin: n = 10 neurons, 11 dendrites. Error bars show SEMs. A.U., arbitrary unit.
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Figure 3. miR-129 binds Kv1.1 RNA when mTORC1 kinase is active. (A) Sequence alignment of Kv1.1 3UTR indicates that the miR-129 seed match se-
quence (binding to nt 2–8 of miR-129) is conserved among rat, mouse, guinea pig, and human, with nt 1 and 8 being less conserved. The miR-129 binding 
site is highlighted in red. This motif is considered to be a “weak” binding site, consistent with a role in translational repression over degradation (Vatolin 
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et al., 2006; Grimson et al., 2007). Note that there are an additional 180 nt after the stop codon in the 3UTR of the rat and mouse sequences that are 
not present in guinea pig and human sequences. Nucleotide number after the stop codon of each sequence shown: Rat, 181–212 nt; mouse, 177–207 nt; 
guinea pig, 1–34 nt; human, 1–35 nt. The NCBI accession numbers are rat M26161.1, mouse NM_010595, and human BC101733.1. For guinea pig, 
the University of California, Santa Cruz genome browser database was used. The sequence is located in scaffold_107:2955798–2955831. The asterisks 
represent the nucleotides that are conserved between rat, mouse, guinea pig, and human. (B, top) Schematic of RNA fragments used as bait to determine 
miR-129 binding to Kv1.1. mTRS is indicated by the gray box illustrating the miR-129 seed match sequence (FL) or the mutated sequence (miR-129). (bot-
tom) qPCR of miR-129 pulled down from DMSO- or rapamycin-treated neurons. *, P < 0.05; ***, P < 0.001; one-way analysis of variance (ANOVA), 
Dunnett’s posttest compared with the FL DMSO. DMSO: FL n = 11, CR n = 8, and miR-129 n = 5; rapamycin (Rapa): FL n = 6, CR n = 8, and miR-129 
n = 4 over at least four independent cultures. CR, coding region; FL, full length. (C, left) Representative neurons transfected with EGFP alone (control) or 
with LNA to specifically knock down miR-129 (KD). Arrowheads indicate Kv1.1 puncta in dendrites. (right) Quantification of dendritic Kv1.1 punctal signal 
intensity. Number of dendrites: control, n = 12; miR-129 KD, n = 14. Nine neurons for each condition. ***, P < 0.001; unpaired Student’s t test. (D, left) 
Representative neurons transfected with EGFP alone (control) or with LNA against miR-129 (KD). (right) Quantification of dendritic Kv4.2 puncta. Number 
of dendrites: control, n = 12; miR-129 KD, n = 17. n = 8 and 10 neurons for control and miR-129 KD, respectively. In C and D, yellow dotted lines were 
drawn to outline representative dendrite in Fig. 3 (C–E). (E, left) Hippocampal neurons transduced with either DsRed control or DsRed pre–miR129-2 lenti-
virus at DIV 14. DMSO- or rapamycin-treated DIV 21 neurons were stained and imaged for RFP and Kv1.1. (right) Quantification of signal intensity. 
***, P < 0.001; one-way ANOVA, Tukey posttest. n = 9 neurons per treatment. Number of dendrites: DMSO-treated rapamycin control, n = 17; n = 14 
and 15 for miR-129 overexpression (OE). A.U., arbitrary unit. Error bars show SEMs. Bars, 20 µm.
 
vitro transcription of cDNAs coding for Kv1.1: full length (FL; 
CR + 3UTR), CR, or FL with the predicted miR-129 binding 
site (seed match sequence) mutated to the complementary se-
quence (miR-129; Fig. 3 B, top). The purified RNAs were 
then labeled with a biotin-linked oligonucleotide (oligo) and 
served as bait to pull down binding factors from neuronal ly-
sates harvested from cultured cortical neurons treated with 
DMSO or rapamycin. Factors that bound to Kv1.1 RNA were 
then precipitated with streptavidin-coated magnetic beads and 
examined by qPCR for the presence of miR-129 (Fig. S2 A).
When mTORC1 kinase is active and Kv1.1 mRNA trans-
lation is suppressed, miR-129 was bound to the FL RNA (Fig. 3 B, 
bar graph). As a negative control, the RNA affinity capture assay 
was performed using in vitro synthesized RNA encoding the CR 
alone or the FL RNA with a mutated miR-129 binding site 
(miR-129). As expected, miR-129 binding was significantly 
reduced under both control conditions relative to the binding of 
the FL RNA (CR: 11 ± 9%, DMSO; miR-129: 6 ± 5%, DMSO). 
However, when mTORC1 kinase was inhibited with rapamycin, 
miR-129 binding to the FL RNA was reduced to 45 ± 15% 
(Fig. 3 B). This level was not different from the background 
binding detected by the two constructs missing the miR-129 seed 
match sequence. Melt curve analysis was performed to verify 
that one product was amplified for miR-129 with a signature 
melting temperature determined by the input (Fig. S2 B). Similar 
to what we observed in cultured neurons, using solubilized SNs 
isolated from rat cortices, the FL RNA bound significantly more 
miR-129 than the CR RNA (52 ± 1% relative to FL; Fig. S2 C). 
These results suggest that miR-129 binds to the 3UTR of Kv1.1 
mRNA when mTORC1 kinase is active.
miR-129 knockdown (KD) in neurons 
increases Kv1.1 expression
We next examined the effect of miR-129 on Kv1.1 expression 
in neurons by transfecting a locked nucleic acid (LNA) probe 
complementary to miR-129 to knock down its level in neurons. 
Total Kv1.1 protein was then determined by immunocytochem-
istry. The protein levels of another dendritic potassium channel, 
Kv4.2, were determined as a control. The effectiveness of miR-
129 KD was established in cortical neurons showing a reduc-
tion in miR-129 levels by Northern blot and an increase in the 
published miR-129 target ERK2 (Fig. S2 D; Wu et al., 2010). If 
miR-129 suppresses the translation of Kv1.1 in dendrites, 
knocking down miR-129 will increase the expression of Kv1.1. 
Indeed, we observed a significant two- to threefold increase in 
signal intensity of Kv1.1 punctate structures in dendrites when 
miR-129 was knocked down compared with the negative EGFP 
or the scrambled LNA controls (Fig. 3 C, miR-129 KD vs. 
EGFP [2.95 ± 0.3]; and Fig. S2 E, miR-129 KD vs. scrambled 
LNA [1.9 ± 0.12]). Moreover, there was no change in Kv1.1 
intensity in the cell body when miR-129 was knocked down 
(Fig. S2 E). Furthermore, no significant change was observed in 
dendritic staining for Kv4.2 (Fig. 3 D and Fig. S2 E). These 
data suggest that miR-129 suppresses the translation of Kv1.1 
mRNA in neuronal dendrites.
Overexpression of miR-129 represses 
Kv1.1 mRNA translation when mTORC1 
kinase is inhibited
To test whether miR-129 mediates repression of Kv1.1 mRNA 
translation when mTORC1 kinase is active, we transduced neu-
rons with a lentivirus coding for a precursor form of miR-129 
(pre–miR-129-2). We predicted that increasing the level of miR-
129 would mimic mTORC1 repression of Kv1.1 mRNA transla-
tion and thus prevent the increase in dendritic Kv1.1 expression 
when mTORC1 kinase is inhibited. Indeed, overexpression of 
miR-129 prevents the observed increase in Kv1.1 dendritic pro-
tein with rapamycin, maintaining levels similar to the mTORC1 
kinase active state (Fig. 3 E and Fig. S2 F). These data suggest 
that miR-129 binding to Kv1.1 mRNA is necessary for repressing 
Kv1.1 translation when mTORC1 is active.
Repression of local protein synthesis of 
Kv1.1 mRNA in neurons is relieved when 
the miR-129 binding site is mutated
To further test the functional role of miR-129 in the regulation 
of Kv1.1 mRNA translation, we performed a local translation 
assay using Kaede fused to Kv1.1 as a translational reporter 
(Raab-Graham et al., 2006). Kaede is a fluorescent protein that 
changes color from green to red upon UV-induced photocon-
version (Ando et al., 2002). To assess new protein synthesis, 
preexistent Kaede-fused protein is first photoconverted to red, 
and newly synthesized green protein can thus be monitored and 
quantitated over time. Neurons expressing Kaede-Kv1.1 mRNA 
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<15 µm/h (Raab-Graham et al., 2006). Based on these data, we 
analyzed only new green Kaede-Kv1.1 puncta >60 µm from the 
cell body to ensure all new protein was locally synthesized.
Z-stack images detecting the green signal were acquired 
over time and pseudocolored to reflect the signal intensity of 
newly synthesized green Kaede-Kv1.1 protein. As shown in 
Fig. 4, mutating the miR-129 site in the 3UTR of Kv1.1 mRNA 
results in an increase in Kv1.1 local mRNA translation by 
with either intact mTRS or with the predicted miR-129 binding 
site (seed match) sequence mutated (miR-129) were imaged for 
2 h after complete photoconversion. Detection of new “green” 
Kaede-Kv1.1 indicates Kv1.1 mRNA translation (Raab-Graham 
et al., 2006). Previously, we have shown that Kv1.1 protein ap-
pears in hot spots within the dendrite when mTORC1 kinase is 
inhibited. Furthermore, Kv1.1 was found to remain stationary 
within these hot spots. Transport rates were measured to be 
Figure 4. Mutating the miR-129 seed match sequence in Kaede-Kv1.1 mRNA results in mTORC1-independent new translation in neuronal dendrites. Live 
imaging of cultured hippocampal neurons expressing Kaede-Kv1.1 with (top, FL) or without (bottom, miR-129) seed match sequence of miR-129 in aCSF 
containing 200 nM DMSO (left, control) or rapamycin (right) before, immediately after (0 time point), and 120 min after UV exposure to photoconvert 
Kaede-Kv1.1. (left) Entire representative neuron. (right) Enlarged representative dendrite, indicated by arrows, >60 µm from the soma. Bars: (main images) 
50 µm; (insets) 10 µm. DMSO: FL, n = 58 puncta and miR129, n = 67 puncta; rapamycin (Rapa): FL, n = 51 puncta and miR-129, n = 64. *, P < 0.05; 
**, P < 0.01; one-way ANOVA, Tukey posttest, relative to Kaede-Kv1.1-FL DMSO. Yellow boxes indicate the region of the dendrite used in the enlarged 
images. The yellow lines outline the representative dendrite. Error bars show SEMs.
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of Kv1.1 may lead to increased excitability and provide an im-
portant positive feedback mechanism for learning and memory, 
homeostatic mechanisms that lower the membrane potential are 
required to maintain neuronal stability and allow new learning 
to occur (Davis and Goodman, 1998; Turrigiano and Nelson, 
2000). Because we identified miR-129 as the translational re-
pressor of Kv1.1 mRNA when mTORC1 kinase is active, how 
inactivating mTORC1 kinase with rapamycin releases such 
translational repression became the next question.
We first asked whether miR-129 levels would decrease 
upon rapamycin treatment, thus limiting the amount available 
to repress translation. To test this possibility, we performed 
qPCR to detect miR-129 in synaptoneurosomal RNA isolated 
from neurons in which mTORC1 kinase was active (control 
with DMSO) or inhibited by rapamycin. Contrary to our predic-
tion, we did not observe a significant change in miR-129 levels 
between control and rapamycin-treated neurons as determined 
by both RT-qPCR and Northern blotting (Fig. 6 A).
An alternative possibility is that additional factors interact 
with Kv1.1 mRNA to relieve repression and promote translation 
when mTORC1 kinase is inhibited. We therefore searched for 
RNA-binding proteins that bind Kv1.1 mRNA in an mTORC1 
kinase–sensitive manner. To find such candidates, we performed 
a bioinformatic scan for known binding sites for RNA-binding 
proteins within the FL Kv1.1 mRNA. We identified three puta-
tive HuD binding sites in the CR of Kv1.1 mRNA (Fig. S4 A), 
consistent with a HuD binding motif previously reported by 
Wang and Tanaka Hall (2001; x-U/C-U-x-x-U/C-U-U/C; Fig. 
S4 A). The Hu family of RNA-binding proteins has an estab-
lished role in stabilizing mRNAs and promoting translation and 
has been shown to be important for dendritic protein synthesis 
(Antic et al., 1999; Bolognani and Perrone-Bizzozero, 2008; 
Tiruchinapalli et al., 2008; Fukao et al., 2009). Moreover, simi-
lar to inhibiting mTORC1 kinase with rapamycin to prevent con-
solidation, mice that overexpress HuD have deficits in learning 
and memory (Bolognani et al., 2007).
To verify the predicted binding of HuD to Kv1.1 mRNA, 
coimmunoprecipitation of transfected HEK293T cells was 
used to assess whether HuD binds directly to Kv1.1 mRNA. 
HEK293T cells were cotransfected with myc-tagged HuD plus 
200% (215.1 ± 22.57%) when mTORC1 kinase was active, 
similar to the signal observed in neurons expressing Kaede-Kv1.1 
with an intact miR-129 site when mTORC1 kinase is inhibited 
with rapamycin. Furthermore, in the absence of the miR-129 site, 
rapamycin treatment did not result in further increased transla-
tion, suggesting that the miR-129 binding site is the mTRS.
Binding of miR-129 leads to repression 
rather than degradation of Kv1.1 mRNA  
in neuronal dendrites
miRNAs have reported roles in both the repression and the deg-
radation of their target mRNAs (Fabian et al., 2010). To verify 
that miR-129 represses translation without altering mRNA sta-
bility, we performed an in situ hybridization using an antisense 
oligo against EGFP (Wells et al., 2001; Raab-Graham et al., 
2006) on neurons expressing EGFP fused to Kv1.1 with either an 
intact or mutated miR-129 binding site (Fig. 5). If miR-129 bind-
ing leads to the degradation of Kv1.1 mRNA, we would predict 
that more RNA will be detected with the removal of the miR-129 
binding site. However, if miR-129 binding represses Kv1.1 
mRNA without degradation, removal of the miR-129 site will 
lead to increased protein expression without altering mRNA lev-
els. As expected, the overall RNA steady-state levels were the 
same between the two sets of neurons (FL, 1.0 ± 0.06; miR-
129, 1.1 ± 0.06; Fig. S3 A), whereas more protein was detected 
in the dendrites expressing Kv1.1 with the mutated sequence, as 
indicated by the ratio of EGFP/in situ hybridization signal (Fig. 5 
and Fig. S3 B, FL [1.0 ± 0.06] and miR-129 [1.4 ± 0.09]). Con-
sidering that the Kv1.1 mRNA level remains constant indepen-
dent of mTORC1 kinase activity (Fig. 1 B) and that mutation of 
the miR-129 binding site does not change mRNA stability, these 
data thus support a mechanism of miRNA-mediated repression 
over degradation.
HuD binds Kv1.1 mRNA when mTORC1 
kinase is inactive and overrides mTORC1 
kinase–dependent repression
During neuronal transmission, signaling through the NMDAR 
via the phosphoinositide 3-kinase–mTORC1 pathway represses 
Kv1.1 mRNA translation. Although such translational repression 
Figure 5. Mutating the miR-129 seed match sequence in EGFP-Kv1.1 RNA increases protein levels without changing RNA levels. Representative images 
of dendritic localization of EGFP-Kv1.1 RNA (red) and protein (green) with the intact (left, FL) or mutated (right, miR-129) miR-129 binding site revealed 
by in situ hybridization (ISH) using a digoxigenin-labeled antisense oligo against EGFP. Bar, 20 µM. n = 12 and 13 neurons for FL and miR-129, 40 
dendrites each. Error bars show SEMs. 
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Figure 6. HuD binds Kv1.1 mRNA when mTORC1 kinase is inhibited and increases Kv1.1 expression that is reversed with cycloheximide. (A, left) RT-qPCR 
amplification of miR-129 from neurons treated with DMSO or rapamycin (Rapa). n = 3 independent cultures, and each sample was performed in triplicate. 
(right) Northern blot analysis showed no significant difference in the expression level of miR-129 between neurons treated with DMSO or rapamycin. 
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The signal intensity for miR-129 was normalized to the signal intensity for let-7a, which remained constant between DMSO- or rapamycin-treated neurons. As a 
loading control, ethidium bromide–stained low molecular weight RNA is shown in the bottom blot (labeled as EtBr). n.s., not significant. (B) RT-PCR ampli-
fication of Kv1.1 mRNA pulled down by HuD in HEK293T cells. HEK293T cells were cotransfected with myc-HuD and Kaede-Kv1.1 FL, CR, or miR-129. 
Antimyc-coated beads were used to pull down HuD bound to Kv1.1 mRNA outlined above. Kv1.1 FL without HuD or Kaede in place of Kv1.1 (bottom) 
were transfected as controls and show no binding to Kv1.1 mRNA or Kaede RNA alone. n = 2 independent cultures. (C, left) Representative neurons (DIV 
14) cotransfected with EGFP and either pcDNA or HuD cDNA. Neurons were treated with 50 µM DMSO or cycloheximide, and Kv1.1 and Kv4.2 were 
detected with specific antibodies. Arrowheads show Kv1.1 puncta (signal). Bars, 20 µm. (right) Quantification of Kv1.1 and Kv4.2 punctal intensity in 
dendrites. Number of dendrites: DMSO-treated Kv1.1 pCDNA, n = 15 and HuD, n = 18; Kv4.2 pCDNA, n = 17 and HuD, n = 16. Cycloheximide (cyclo)-
treated Kv1.1 HuD, n = 14 and Kv4.2 HuD, n = 17. ***, P < 0.001; one-way ANOVA, Tukey’s posttest. #, Kv4.2 punctal intensity significant from DMSO 
+ HuD. (D) RT-PCR amplification of Kv1.1 (top), GAP-43, or CaMKII (middle) mRNA copurified with GST-HuD or GST from DMSO- or rapamycin-treated 
cortical neurons (DIV 21). (bottom) GAPDH mRNA was detected in input but not pull-down. The ratio (rapamycin/DMSO; right of the images) is determined 
by subtracting signal intensity of the background GST band from the specific GST-HuD band and normalizing each band by their respective GAPDH input 
mRNA levels. HuD-RNA pull-down was replicated with three independent cultures for Kv1.1 mRNA and two independent cultures for CaMKII and GAP-43 
mRNA. Significance for each mRNA was determined by a single Student’s t test. *, P < 0.05, indicating the binding is significantly different from 1. A value 
of 1 suggests equal binding in both treatments. Error bars show SEMs. rRNA, ribosomal RNA.
 
either Kaede-Kv1.1 FL, Kaede-Kv1.1 CR, or Kaede-Kv1.1 
miR-129. mRNA protein complexes (messenger RNPs) contain-
ing HuD were immunoprecipitated from lysates using a myc-
specific antibody. Bound Kv1.1 mRNAs were then detected by 
RT-PCR using Kv1.1-specific primers. To control for antibody 
specificity, HEK293T cells were transfected with Kaede-Kv1.1 
and an empty vector without myc-HuD. We also included a 
negative control for nonspecific PCR amplification using myc-
HuD and Kaede alone. As expected, Kaede-Kv1.1 FL, CR, and 
miR-129 mRNA all copurified with HuD protein (Fig. 6 B). 
This result is consistent with the predicted HuD binding ele-
ments found within the CR of Kv1.1 mRNA (Fig. S4 A). Addi-
tionally, Kv1.1-specific PCR products were only detected from 
RNA immunoprecipitated from lysates expressing HuD and 
Kv1.1 (Fig. 6 B). Collectively, these results suggest that HuD 
binds to the CR of Kv1.1 mRNA. A similar mechanism was 
recently shown for another member of the Hu protein family, 
HuR, which was found to displace miRNA-induced silencing 
complexes from target mRNAs even when its binding site and 
the miRNA site were not adjacent (Kundu et al., 2012).
A direct prediction of this hypothesis is that increasing HuD 
protein when mTORC1 kinase is active will overcome miR-129–
mediated repression of Kv1.1 mRNA. To test this, we overex-
pressed HuD in cultured hippocampal neurons and measured 
dendritic Kv1.1 protein. Fig. 6 C shows that under conditions in 
which mTORC1 kinase is active, neurons overexpressing HuD 
show a significant three- to fourfold (3.7 ± 0.41) increase of Kv1.1 
punctal intensity in dendrites with no significant change in Kv1.1 
levels in the cell body (Fig. S4 B). Kv4.2 signal is not affected by 
HuD overexpression. This increase in Kv1.1 punctal signal is spe-
cifically inhibited by the presence of the well-characterized protein 
synthesis inhibitor cycloheximide (0.3 ± 0.04). Notably, cyclohex-
imide further decreases the levels of both Kv1.1 and Kv4.2 relative 
to the control condition, indicating a decrease in basal translation 
(Kv1.1, 0.3 ± 0.04; Kv4.2, 0.4 ± 0.05). These results suggest that 
overexpression of HuD overrides mTORC1 kinase/miR-129– 
dependent repression of Kv1.1 mRNA translation.
We next tested whether HuD binding to Kv1.1 mRNA is 
altered with mTORC1 kinase activity. Purified GST-HuD fu-
sion protein was incubated with total RNA isolated from carrier 
DMSO- or rapamycin-treated neurons and immunoprecipitated 
with a pan-Hu antibody (Deschênes-Furry et al., 2007). Bound 
Kv1.1 mRNAs were then detected by RT-PCR with gene-specific 
primers. GAP-43 and CaMKII mRNAs, known targets of HuD 
(Bolognani et al., 2006, 2010; Tiruchinapalli et al., 2008), were 
also assayed in parallel as controls. The differential binding of 
HuD with different mTORC1 activity to the three mRNAs 
assayed is reflected by the quantified ratio of mRNA pulled 
down in rapamycin over DMSO, as shown in Fig. 6 D (note: a 
ratio of one indicates equal binding under both conditions, a 
ratio greater than one favors binding in the presence of rapamy-
cin, and a ratio less than one favors binding in DMSO). Interest-
ingly, HuD only binds to GAP-43 mRNA in neurons treated 
with DMSO (rapamycin/DMSO ratio significantly smaller 
than 1, one-sample t test, P < 0.05; Fig. 6 D), whereas HuD binds 
CaMKII mRNA under both conditions (rapamycin/DMSO 
bound ratio = 1.4 ± 0.4 SD and was not considered significant 
from 1 by a one-sample t test; Fig. 6 D). In contrast, HuD only 
binds Kv1.1 mRNA in neurons treated with rapamycin (with a 
ratio of 8.6 ± 0.7 SD, one-sample t test, P < 0.05; Fig. 6 D). The 
result that HuD only binds Kv1.1 mRNA in neurons treated 
with rapamycin supports a role for HuD in promoting Kv1.1 
mRNA translation when mTORC1 is inhibited.
HuD binding to Kv1.1 mRNA coincides 
with the reduced level of other HuD  
target mRNAs
We next asked whether HuD protein levels increase with 
mTORC1 kinase inhibition, which could lead to enhanced den-
dritic Kv1.1 levels. Western blot analysis using a HuD-specific 
antibody was performed on DMSO- or rapamycin-treated SNs. 
Contrary to what we expected, HuD levels significantly decrease 
when mTORC1 was inhibited (Fig. 7 A, DMSO [1.00 ± 0.06] 
and rapamycin [0.63 ± 0.09]).
We then considered the possible relationship between 
mTORC1 activity and the abundance of other HuD targets. 
Notably in Fig. 6 D, the total input of the high affinity HuD- 
target CaMKII with 32 predicted binding sites, some of which 
overlap (Bolognani et al., 2010), appears to be reduced when 
mTORC1 kinase is inhibited with rapamycin. To verify this ob-
servation in a quantitative manner, we performed RT-qPCR for 
CaMKII and Kv1.1 mRNAs by isolating total RNA from neu-
rons treated with DMSO or rapamycin. As expected, CaMKII 
mRNA was reduced by 70% when mTORC1 kinase was in-
hibited with rapamycin (rapamycin, 33.6 ± 12.5% of control). 
Furthermore, when we assessed the relative abundance of two 
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Figure 7. HuD binding to Kv1.1 mRNA coincides with reduced levels of 
other HuD-target mRNAs. (A) Western blot analysis of HuD from SNs iso-
lated from neurons treated with DMSO or rapamycin. DMSO, n = 3; rapa-
mycin (Rapa), n = 4 over two independent cultures. (B) RT-qPCR analysis of 
CaMKII, GAP-43, Homer1a, and Kv1.1 mRNA isolated from control or 
200 nM rapamycin-treated neurons normalized to the internal housekeep-
ing gene, GAPDH, which remains constant between the two conditions. 
CaMKII and Kv1.1, n = 3; GAP-43, n = 5; Homer1a, n = 4; three to 
five independent cultures. Control was normalized to 100% and is indi-
cated by dotted line on the graph. The mRNA target of HuD is shown as 
percent remaining after rapamycin treatment. One-sample Student’s t test 
was performed to determine statistical significance from control. (C) Rep-
resentative blot and quantification of SN CaMKII protein isolated from 
DMSO- or rapamycin-treated cortical neurons. DMSO, n = 5; rapamycin, 
n = 6. (D) Neurons were treated with 12 µM Actinomycin D (Act D) for 
4–5 h before treating with DMSO or rapamycin for 75 min. Degradation 
was measured by RT-qPCR for CaMKII mRNA and reported as the percent 
decrease with the addition of rapamycin relative to actinomycin alone. 
n = 5 per treatment. The solid line is connecting the mean for actinomycin 
alone to the mean for 75- min DMSO + actinomycin treatment. The dotted 
line is connecting the mean for actinomycin alone to the mean for 75-min 
rapamycin + actinomycin treatment. *, P < 0.05; ***, P < 0.001. Error 
bars show SEMs.
 
additional HuD targets, GAP-43 and Homer1a, we found they 
were both reduced by 40% and were significantly different 
from control (GAP-43: rapamycin, 58.9 ± 14% of control; 
Homer1a: rapamycin, 59 ± 12% of control; Fig. 7 B). In contrast, 
Kv1.1 mRNA levels remained the same between the two condi-
tions (Kv1.1: rapamycin, 89 ± 27% of control; Fig. 6 D, input; 
and Fig. 7 B). Moreover, the reduction of CaMKII mRNA is 
also reflected by the reduced protein level when mTORC1 kinase 
is inhibited (Fig. 7 C). Collectively, these data led us to consider 
the possibility that HuD switches its targets in accordance with 
the mRNAs that are available to be translated.
To determine whether mTORC1 activity affects high af-
finity HuD-target mRNA levels at the transcriptional level or 
causes mRNA degradation, we treated neurons with the tran-
scriptional inhibitor actinomycin for 4 h before inhibiting 
mTORC1 activity with rapamycin and determined the mRNA 
levels of CaMKII. We predicted that if mTORC1 activity reg-
ulates the transcription of CaMKII, pretreatment with actino-
mycin will reflect the same changes in mRNA levels as observed 
with rapamycin treatment alone. However, if inhibition of 
mTORC1 kinase activity by rapamycin promotes the degrada-
tion of CaMKII mRNA, rapamycin treatment in the presence 
of a transcriptional inhibitor will further decrease the amount of 
CaMKII mRNA. As shown in Fig. 7 D, qPCR analysis of 
CaMKII mRNA levels showed a reduction by 61% (actinomy-
cin, 100 ± 0.9%; actinomycin + rapamycin, 39 ± 18.3%) in neu-
rons treated with both actinomycin and rapamycin relative to 
actinomycin alone, supporting CaMKII mRNA degradation 
over altered transcription upon mTORC1 inhibition (Fig. 7 D).
Overexpression of CaMKII UTRs prevents 
the increase in dendritic Kv1.1 protein 
when mTORC1 kinase is inhibited
If HuD binding to Kv1.1 mRNA requires the degradation of 
high affinity targets such as CaMKII mRNA, overexpression 
of CaMKII mRNA containing several HuD binding sites may 
affect the dendritic expression of Kv1.1 protein. We tested this 
prediction by overexpressing GFP-fused UTRs of CaMKII 
(5UTR-GFP-3UTR of CaMKII; Aakalu et al., 2001) in neu-
rons and measured the resulting dendritic Kv1.1 protein levels. 
The overexpressed CaMKII 3UTR is predicted to carry eight 
overlapping HuD binding sites (Fig. S4 C). The ability of HuD 
to promote translation of this construct was first tested in 
HEK293T cells. Coexpression of HuD and GFP-CaMKII 
UTRs demonstrated a functional interaction by increasing the 
expression of GFP by approximately threefold over GFP-CaM-
KII UTRs alone (Fig. S4 D, vector-only control [1.00 ± 0.26] 
and HuD [3.24 ± 0.59]). We then tested whether providing ex-
cess CaMKII UTRs for HuD binding in neurons will pre-
vent the observed increase in Kv1.1 protein with mTORC1 kinase 
inhibition. Indeed, dendritic Kv1.1 protein levels no longer 
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increased with rapamycin treatment in the presence of excess 
CaMKII UTRs (Fig. 8 A, GFP + DMSO [1.00 ± 0.12], GFP + 
rapamycin [1.58 ± 0.11], CaMKII UTRs + DMSO [1.13 ± 
0.14], and CaMKII UTRs + rapamycin [0.88 ± 0.11]). To ver-
ify that repression of Kv1.1 mRNA translation with excess 
CaMKII UTR in the presence of rapamycin is caused by HuD 
binding this construct, we removed the predicted HuD binding 
sites within the 3 UTR (CaMKII UTRHuD) by PCR-based 
deletion. Indeed, with mTORC1 inhibition, dendritic Kv1.1 
protein expression was restored and insensitive to overexpres-
sion of CaMKII UTRHuD relative to neurons expressing 
CaMKII UTR (Fig. 8 B, CaMKII UTRs + DMSO [1.00 ± 
0.09], CaMKII UTRs + rapamycin [1.36 ± 0.11], CaMKII 
UTRsHuD + DMSO [1.24 ± 12], and CaMKII UTRsHuD + 
rapamycin [2.48 ± 0.21]). These results suggest that CaMKII 
and Kv1.1 mRNAs compete for HuD binding enabling transla-
tion. Collectively, our results support the hypothesis that 
mTORC1 kinase affects Kv1.1 mRNA translation by changing 
the availability of HuD via degradation of other high affinity 
HuD-target mRNAs.
Discussion
Reversible binding of RNA-binding factors 
to Kv1.1 mRNA with mTORC1 activity 
regulates dendritic expression of Kv1.1
mTORC1 regulation of Kv1.1 mRNA translation provides an 
example for how RNA-binding factors may determine the bidi-
rectional expression of dendritic ion channels. As depicted in 
Fig. S5, our findings support a model in which the levels of 
Kv1.1 expression can be titrated by the interplay between 
mTORC1 kinase–dependent reversible binding of miR-129 
and HuD to Kv1.1 mRNA. We have provided several lines of 
evidence demonstrating the repressive role of miR-129. We 
found that miR-129 binds to Kv1.1 mTRS only when mTORC1 
kinase is active and knocking down miR-129 in neurons in-
creases Kv1.1 expression in dendrites, whereas overexpress-
ing miR-129 prevents the rapamycin-dependent increase in 
dendritic Kv1.1. Consistent with these results, mutating the 
miR-129 binding site released the local translation of Kv1.1 
mRNA from mTORC1 kinase–mediated repression. All these 
Figure 8. Overexpression of the CaMKII UTR with multiple HuD sites occludes the increase in dendritic Kv1.1 expression. (A) Representative neurons 
(DIV 21) transfected with cDNA coding for EGFP or dGFP CaMKII UTRs were treated with 200 nM DMSO or rapamycin (Rapa), fixed, and immuno-
stained for EGFP and Kv1.1. Quantification of dendritic Kv1.1 signal intensity for control (EGFP) or CaMKII UTR overexpression normalized by baseline 
signal for dendritic Kv1.1 under control conditions (EGFP/DMSO). Number of dendrites: DMSO-treated control, n = 22 and CaMKII UTR overexpression (OE), 
n = 29; rapamycin-treated control, n = 33 and CaMKII UTR overexpression, n = 31. *, P < 0.05; **, P < 0.01; ***, P < 0.001; one-way ANOVA, 
Tukey’s posttest. (B) Representative neurons expressing dGFP CaMKII UTR without the putative HuD binding sites treated with 200 nM DMSO or rapa-
mycin were quantitated as outlined in A of this figure. Number of dendrites: CaMKII UTR overexpression with DMSO control, n = 20; CaMKII UTR over-
expression with rapamycin, n = 23; HuD overexpression with DMSO, n = 20; HuD overexpression with rapamycin, n = 24. ***, P < 0.001 relative to 
all other conditions; one-way ANOVA, Tukey’s posttest. Arrows show Kv1.1 puncta (signal). Yellow dotted lines were drawn to outline the representative 
dendrite. Error bars show SEMs. Bars, 20 µm. A.U., arbitrary unit.
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The discovery of mTORC1-mediated switching of HuD 
binding targets provides clues for the importance of mTORC1 in 
memory. As memory requires both the induction of positive reg-
ulators (such as CaMKII, which can enhance synaptic strength) 
and the removal of negative constraints (such as potassium chan-
nels that can dampen action potentials; Abel et al., 1998), trans-
lational control of those regulators by HuD via mTORC1-mediated 
mRNA degradation is thus conceivably important for memory. 
Our findings may thus explain why HuD has been found to be 
important for memory (Bolognani et al., 2004; Pascale et al., 
2004), but overproduction of HuD in transgenic mice led to 
memory deficits (Bolognani et al., 2007). In other words, the 
physiological role of HuD may be determined by the ratio of 
available high to low affinity targets such as CaMKII and 
Kv1.1, respectively.
Because hundreds of dendritic mRNAs have been identi-
fied (Martin and Zukin, 2006; Cajigas et al., 2012) and Kv1.1 
was the first example of a voltage-gated ion channel being lo-
cally translated (Raab-Graham et al., 2006), other mRNAs that 
are critical to site-specific changes in dendritic excitability may 
use the same mechanism to regulate their local translation. Our 
study may thus lead to the future discovery of other functionally 
related mRNAs suppressed by mTORC1 kinase activity. More-
over, Kv1.1, miR-129, and HuD may serve as important tar-
gets and/or biomarkers for mTORC1 kinase–related diseases, 
such as epilepsy, Fragile X syndrome, tuberous sclerosis com-




Primary antibodies used were as follows: mouse anti-NeuN (1:500; EMD 
Millipore), mouse anti-Kv1.1 extracellular, (1:1,000; 75–105; NeuroMab), 
mouse anti-Kv1.1 (1:1,000; 75–007; NeuroMab), mouse anti-Kv4.2 (75–
016; NeuroMab), rabbit anti-Kaede (1:500; PM012; MBL International), 
rabbit antiphospho-mTOR (1:500; 2971S; Cell Signaling Technology), 
mouse antitubulin (1:1,000; T6074; Sigma-Aldrich); rabbit anti-HuD (epi-
tope: 26–42 nt; 1:1,000; AB5971; EMD Millipore), rabbit anti-ERK2 
(1:1,000; 9108S; Cell Signaling Technology), rabbit antimyc (1:150; 
c3956; Sigma-Aldrich), rabbit anti-GFP (1:1,000; ab6556; Abcam), and 
rabbit anti-HuD (for GST pull-down; sc-25360; Santa Cruz Biotechnology, 
Inc.). Western blot signals were detected by secondary antibodies conju-
gated to HRP (1:1,000; Jackson ImmunoResearch Laboratories, Inc.) for 
chemiluminescence or infrared-conjugated secondary antibodies (IR680 at 
1:5,000; IR800 at 1:5,000) for the infrared imaging system (Odyssey; 
LI-COR Biosciences). For immunostaining, secondary antibodies conjugated 
to either Alexa Fluor 488 (1:400; Invitrogen), Cy3 (1:500; Jackson Immuno-
Research Laboratories, Inc.), Alexa Fluor 647 (1:200; Invitrogen), or Cy5 
(1:200; Jackson ImmunoResearch Laboratories, Inc.) were used.
Preparation of primary cultured neurons
Primary neurons were prepared as previously described (Ma et al., 2002). 
In brief, cortices from embryonic day 18–19 (E18–19) rats were collected, 
dissociated, and plated. Neurons were plated at densities of 15 million 
neurons/100-mm dish for affinity RNA capture experiments, 2 million/ 
35-mm well for Western blotting and qPCR, 400,000 neurons/12-mm 
coverslip for imaging in Fig. 2, and 200,000 neurons/12-mm coverslip for 
imaging in Fig. 3.
Isolation of SNs and neuronal lysates
SNs were isolated by a modified method as previously described (Quinlan 
et al., 1999). In brief, neurons were harvested in buffer B (20 mM Hepes, 
pH 7.4, 5 mM EDTA, pH 8.0, protease inhibitor cocktail [Complete; 
Roche], phosphatase inhibitor, and RNase inhibitor SUPERase-In [Ambion] 
data suggest that NMDAR activation (Raab-Graham et al., 2006) 
and mTORC1 kinase signaling may lead to a positive feedback 
mechanism that reduces the expression of Kv1.1 channels via 
miR-129, perhaps rendering the dendrite more excitable (Fig. S5, 
left dendrite).
A major concern of a positive feedback loop is that if left 
unchecked, it will lead to neuronal instability and prevent fur-
ther acquisition of new information (Turrigiano and Nelson, 
2000). Our findings support a homeostatic mechanism to pos-
sibly reduce dendritic excitability by increasing Kv1.1 mRNA 
translation via the RNA-binding protein HuD. We found that 
expression of dendritic Kv1.1 is determined by mTORC1 kinase–
dependent availability of HuD for Kv1.1 mRNA in the den-
drite. We show that HuD binds to high affinity mRNA targets, 
such as CaMKII mRNA, when mTORC1 kinase is active. 
Those mRNAs degrade when mTORC1 kinase is inhibited, thus 
releasing HuD to bind to the CR of Kv1.1 mRNA and possibly 
releasing miR-129–containing miRNA-induced silencing com-
plex from the 3UTR of this mRNA. Furthermore, neurons 
overexpressing HuD show protein synthesis–dependent increase 
of Kv1.1 expression. We thus propose that HuD binds to Kv1.1 
mRNA when mTORC1 kinase is inhibited and promotes its 
translation (Fig. S5, right dendrite). Collectively, our results 
suggest that mTORC1 kinase serves as a molecular switch for 
bidirectional changes in dendritic expression of Kv1.1.
One surprising and novel finding from our data is that 
mTORC1 kinase activity affects the degradation of high affinity 
HuD mRNA targets, such as CaMKII, GAP-43, and Homer1a, 
instead of affecting miR-129 or HuD levels to favor Kv1.1 
mRNA binding. In yeast, rapid degradation of some mRNAs, 
but not all, has been reported with nutrient limitation or TORC1 
kinase inhibition by accelerating the deadenylation–decapping 
pathway (Albig and Decker, 2001). To our knowledge, our 
study is the first example of mRNA degradation serving as a 
way to recycle RNA-binding factors and thus promote the trans-
lation of other targets. Consistent with a recycling mechanism, 
overexpression of CaMKII UTRs occludes the increase in 
dendritic Kv1.1 protein in rapamycin-treated neurons. Further-
more, with mTORC1 inhibition, CaMKII UTRs with the HuD 
binding sites removed rescued this reduction of endogenous 
dendritic Kv1.1. Our results thus suggest that changing the local 
availability of the regulatory factors may provide a rapid and 
spatially restricted response, therefore bypassing the need for 
new transcription or translation of those factors.
miR-129 and HuD may be important 
regulators of memory and disease mediated 
by mTORC1 activity
The importance of miRNAs in neuronal development and plas-
ticity is emerging (Kosik, 2006; Schratt, 2009). miR-129 has 
been identified to be specifically enriched in the brain (Kim 
et al., 2004; Miska et al., 2004; Landgraf et al., 2007); however, its 
role in neuronal function has not been identified. Our data reveal 
that miR-129 represses the expression of Kv1.1 when mTORC1 
is active, which may partially contribute to the increased risk for 
seizures in disease states with hyperactive mTORC1 kinase (Zeng 
et al., 2009; Sharma et al., 2010; Sahin, 2012).
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Immunofluorescence and image analysis
Immunofluorescence was performed as outlined in Raab-Graham et al. 
(2006). For staining of total protein, neurons were fixed with 4% paraformal-
dehyde, permeabilized with 0.25% Triton X-100, and incubated with primary 
antibodies overnight at 4°C. Secondary antibodies conjugated to either Alexa 
Fluor 488 (1:400; Invitrogen), Cy3 (1:500; Jackson ImmunoResearch Labo-
ratories, Inc.), Alexa Fluor 647 (1:200; Invitrogen), or Cy5 (1:200; Jackson 
ImmunoResearch Laboratories, Inc.) were used in appropriate combinations. 
For staining of surface-expressed Kv1.1, fixed but nonpermeabilized neurons 
were incubated overnight at 4°C with Kv1.1 antibody (1:1,000; NeuroMab) 
that recognizes the extracellular epitope. Neurons were washed extensively 
with PBS for ≥1 h to remove all excess antibodies before permeabilization. 
Z-stack images were acquired using an SP5 (DM6000 CFS; Leica) confocal 
microscope (63× oil objective lens, NA 1.2) by sequential scanning. The 
LAS AF software (Leica) was used for imaging acquisition. Dendrites were 
chosen blindly based on Kaede or EGFP signals that were ≥60 µm in length. 
Signal intensity of puncta was determined by first tracing dendrites ≤150 µm 
on maximum projected images using the line scan tool in the LAS AF soft-
ware package. Background was subtracted by determining the signal in a 
region close to the dendrite but void of all processes. Signal intensity for Kv1.1 
puncta was defined as peaks that exceeded the mean signal intensity in con-
trol dendrites plus 1 SD.
Cell body analysis
For analysis of cell bodies, a region of interest encompassing the cell body 
was drawn using ImageJ (National Institutes of Health). The mean intensity was 
measured for Kv1.1 and normalized to Kaede (Fig. S1 C), DsRed (Fig. S2 F), or 
EGFP (Fig. S2 E and Fig. S4 B). All integrated signal intensities were between 
the range of 0 and 255, to ensure that measurements were taken within the 
linear range.
RNA affinity capture of miRNAs associating with Kv1.1 mRNA
Kv1.1 FL, CR, or miR129 was PCR amplified using primers containing a T7 
promoter and an extra connecting sequence of 20 nt. The PCR products 
were then purified and in vitro transcribed with T7 polymerase (Ambion) to 
generate RNA. The RNA fragments were then purified and hybridized with 
the synthesized biotin oligo (Integrated DNA Technologies) against the 20-nt 
tag, resulting in 5-specific biotin labeling of the RNA. 40 µg cell extract from 
SNs or total neurons was then used to incubate with 4 µg biotinylated RNA 
for 1 h at RT in reaction buffer (10 mM Hepes, pH 7.4, 150 mM NaCl, 
3 mM MgCl2, 2.5% glycerol, 0.5% NP-40, 0.2 mg/ml yeast tRNA, protease 
inhibitor cocktail, 5 mM EDTA, 40 U/ml RNase inhibitor, and 0.2 mM tris 
(2-carboxyethyl) phosphine [TCEP]). The associated protein–RNA complex 
was pulled down with 10 µl streptavidin-coated magnetic beads (Promega) 
by additional incubation of 1 h at RT. The magnetic beads were then 
washed three times with reaction buffer and eluted with high salt buffer 
followed by heating at 95°C for 5 min. The eluent was subjected to miRNA 
detection using miRNA PCR system (Exiqon) with primers specific for 
miR-129 (Exiqon).
qPCR for mRNA or miRNA
qPCR was performed by using a SYBR Green PCR Master Mix as outlined 
by the manufacturer (Applied Biosystems) using a real-time PCR detection 
system (iCycler IQ; Bio-Rad Laboratories). Fold changes were calculated as 
outlined by Raab-Graham et al. (2006). For steady-state mRNA quantifica-
tion (Fig. 1 B), primers against GAPDH were used as an internal house-
keeping gene to control for variation between samples. For miRNA 
pull-down (Fig. 3), 10% total input RNA was used for internal control. All 
experiments were performed in triplicate. Relative ratios were calculated 
by the equation, ratio = (2CPtarget(control  sample)/2CPreference(control  sample)), 
adapted from Pfaffl (2001), in which CP is the threshold cycle, the target is 
the transcript of interest, and the reference is GAPDH, 5S ribosomal RNA, 
or 10% total RNA.
Primers used
For cloning of MAP2-DTS, forward primer, 5-GGCGCGGCCGCG-
ATCTAGCACTAAAATATCATTTTTC-3, and reverse primer, 5-GCGGTCT-
AGATTACTGGACCTTCTTCTTTAGTTACC-3 were used. For in vitro 
transcription of RNA for RNA affinity capture assay, Kv1.1 FL forward 
primer, 5-CCAAGCTTCTAATACGACTCACTATAGGGAGAGGCCGGA-
CAACGTCAAGGCTATGACGG-3, and reverse primer, 5-GTTGG-
GTTTTTTTTTTCTTTTTGCTTGTTTGG-3, were used; for mTRS, we used the 
same forward primer as FL and reverse primer, 5-TTAAACATCGG-
TCAGGAGC-3. For 5-specific biotinylation of mRNAs, biotin-labeled 
5-AGCCTTGACGTTGTCCGGCC-3 was used to hybridize with in vitro 
transcribed mRNAs.
or RNaseOUT [Invitrogen] at 40 U/ml) and homogenized. After pelleting 
nuclei and unbroken cells at 80 g for 10 min, the supernatant was filtered first 
through a sterile 100-µm nylon filter followed by a 5-µm filter. SN was pelleted 
at 14,000 g for 20 min. For mRNA quantification, total RNA was isolated 
using RNeasy columns as outlined by the manufacturer (QIAGEN). For miRNA 
experiments, total RNA was isolated using TRI reagent (Applied Biosystems). 
For RNA affinity capture, SN pellet was solubilized with radioimmunoprecipi-
tation assay buffer (150 mM NaCl, 10 mM Tris, pH 7.4, 0.1% SDS, 1% Triton 
X-100, 1% deoxycholate, and 5 mM EDTA supplemented with protease in-
hibitor cocktail tablet and RNase inhibitor) at 4°C overnight and centrifuged 
at 55,000 g for 1 h to remove any insoluble aggregates. For neuronal lysates, 
21 d in vitro (DIV) cultured cortical neurons were harvested, homogenized, 
and centrifuged similarly as SNs without further filtrations or centrifugation. 
The supernatant after removing the postsupernatant 1 pellet was collected and 
used for RNA affinity capture experiments.
Measure SN purity
Before SN preparation, an aliquot was removed and served as the total ly-
sate. Total and concentrated SN was smeared directly onto glass slides, 
fixed, permeabilized, and then stained using DAPI (1:1,000) wash in PBS. 
This was imaged using a 20× objective. This staining method was adapted 
from Williams et al. (2009).
Sindbis virus generation
All the constructs listed in this section were subcloned into SinRep5 virus 
vector (Invitrogen), and pseudovirions were produced according to the 
manufacturer’s directions.
Kaede-Kv1.1-mTRS. Kaede-Kv1.1 in the SinRep5 vector was di-
gested with BclI. The region of DNA between nt 153 and 1,477 (NCBI 
Nucleotide accession no. M26161) was dropped out. The backbone 
DNA was religated.
Kaede-MAP2-DTS. The 3UTR of MAP2 between nt 2,418 and 3,096 
(NCBI Nucleotide accession no. U30938) was cloned by PCR using spe-
cific primers, including a NotI restriction site in the forward primer and an 
XbaI site in the reverse primer (listed in the Primers used section; Blichen-
berg et al., 1999). The PCR product was digested with NotI and XbaI and 
ligated into the corresponding restriction sites within the multiple cloning 
site after the stop codon of Kaede in the Living Color vector (Takara Bio 
Inc.). Kaede-MAP2-DTS was subcloned into the SinRep5 vector by a blunt-
end ligation.
Kaede-Kv1.1, EGFP-Kv1.1 FL, and miR-129. Kaede or EGFP fused to 
FL Kv1.1 CR and mTRS were previously cloned into pCDNA3 as described 
in Raab-Graham et al. (2006). Mutation of miR-129 binding site (seed 
match sequence) was then achieved by performing site-directed muta-
genesis (QuikChange; Agilent Technologies) using primers 5-CAAAACC-
AACCAAACAACGTTTTTGAAAAAAAAAACCCAAC-3 and 5-GTTGGG-
TTTTTTTTTTCAAAAACGTTGTTTGGTTGGTTTTG-3 (mutations are indicated 
as underlined sequences). The resulting constructs were then subcloned into 
SinRep5 vector for virus production.
Competition assays
For Fig. 2, DIV 21 cortical neurons were infected with Sindbis virus coding 
for Kaede-MAP2-DTS (control) or Kaede-Kv1.1-mTRS. 18 h after infection, 
neurons were treated with 200 nM DMSO or rapamycin in Hepes-based 
artificial cerebral spinal fluid (aCSF) for 75 min at 37°C. After treatment, 
neurons were fixed with 4% paraformaldehyde for 10 min on ice. Neurons 
were immunostained and imaged as outlined in the Immunofluorescence 
and image analysis section. Surface expression was quantitated by blindly 
choosing Kaede-positive neurons.
For Fig. 8, CaMKII 5 → 3UTR fused to destabilized GFP (dGFP; 
dGFP-5, 3UTR) cDNA was obtained from Addgene, generously deposited 
there by M. Sutton (University of Michigan, Ann Arbor, MI) and reported by 
Aakalu et al. (2001). DIV 17 neurons were transfected with EGFP (control) or 
dGFP- CaMKII-5, 3UTR cDNA alone. At DIV 21, transfected neurons were 
treated with 200 nM DMSO or rapamycin for 100 min at 37°C. After treat-
ment, they were fixed with 4% paraformaldehyde for 20 min at RT. Neurons 
were immunostained and imaged as outlined under immunofluorescence. 
Putative HuD binding sites were removed by QuikChange mutagenesis using 
two complimentary oligos (sense strand, 5-CACTCACACCACTTCCTTC-
CACCACTCTCTCCCTCTTCCTGGGTTTGGCTC-3; antisense strand, 
5-CACTCACACCACTTCCTTCCACCACTCTCTCCCTCTTCCTGGGTTTG-
GCTC-3). The PCR protocol used to generate loop out was 95°C for 1 min 
followed by 20 cycles of 95°C for 30 s, 50°C for 1 min, and 68°C for 22 min. 
Nucleotides removed are highlighted in yellow in Fig. S4 C.
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In situ hybridization of Kv1.1 mRNA in cultured neurons
For in situ hybridization of infected neurons, cultures (DIV 21–28) were in-
fected with Sindbis virus encoding either EGFP-Kv1.1 or EGFP as outlined 
previously (Raab-Graham et al., 2006). In brief, 18 h after infection, DIV 
21–28 neurons were fixed in 4% paraformaldehyde and 4% sucrose for 
18 min on ice. Neurons were washed three times in PBS and once in SSC 
for 5 min. Neurons were permeabilized with 1% Triton X-100 and SSC for 
30 min at RT followed by EGFP antisense (nucleotide, 5-ATATAGACGTT-
GTGGCTGTTGTAGTTGTACTCCAGCTTCT-3) digoxigenin-labeled oligo 
hybridization with an overnight incubation at 37°C. Digoxigenin-labeled 
oligo was detected using a mouse antidigoxigenin antibody (Roche) fol-
lowed by an anti–mouse Cy5 antibody (Jackson ImmunoResearch Labora-
tories, Inc.; laboratory of R.H. Singer, Albert Einstein College of Medicine, 
New York, NY).
Transfection and isolation of HEK293T cells
HEK293T cells were transfected with Lipofectamine 2000 as outlined by 
the manufacturer (Invitrogen). 48 h after transfection, cells were harvested 
by scraping the cells into buffer A (mM: 150 NaCl, 10 Hepes, pH 7.4, 
3 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 250 sucrose, and 5 TCEP) contain-
ing protease inhibitors (Complete) and phosphatase inhibitors (Sigma- 
Aldrich). Cells were lysed by homogenization. Lysates were centrifuged at 
106 g for 10 min at 4°C. Supernatant was transferred to a new tube and 
centrifuged for 17,000 g for 20 min at 4°C. P2 pellet was resuspended in 
100 µl buffer A. SDS sample buffer was added to a final concentration of 
1×, and samples were resolved on a 10% SDS-PAGE gel and transferred 
to nitrocellulose for Western blot analysis.
HuD pull-down of Kv1.1 mRNA from HEK293T cells
HEK293T cells were cotransfected with pCDNA3-myc-HuD and pCDNA3-
Kaede-Kv1.1 FL, CR, or miR-129. pCDNA3 alone and Kaede alone were 
used as controls. Cell lysates were harvested in polysome lysis buffer 
(100 mM KCl, 5 mM MgCl2, 10 mM Hepes, 0.5% NP-40, 0.4 µl/ml TCEP, 
100 U/ml RNaseOUT, 0.2% vanadyl ribonucleoside complexes, and EDTA-
free protease inhibitor tablet) followed by homogenization. After centrifuga-
tion at 14,000 g, 4°C, for 10 min, the supernatant was precleared with 
20 µl/ml protein A/G beads (Santa Cruz Biotechnology, Inc.) for 1 h at 4°C. 
Protein A/G beads (20 µl/reaction) were coated with myc antibody (2 µg/
reaction; Sigma-Aldrich) by incubating at RT for 2 h in NT2 buffer (50 mM 
Tris, pH 7.4, 150 mM NaCl, 1 mM MgCl2, 0.05% NP-40, 15 mM EDTA, 
8 U/ml RNaseOUT, and 0.4 µl/ml TCEP) supplemented with 5% BSA. The 
myc antibody–coated beads were then washed six times in NT2 buffer. Pre-
cleared lysates were incubated with myc antibody–coated beads or beads 
alone in NT2 buffer supplemented with 3 µl/ml RNaseOUT at 4°C overnight. 
After washing six times with NT2 buffer, beads were treated with protease K 
(30 µg/ml in NT2 buffer containing 0.1% SDS) at 55°C for 30 min and sub-
jected to RNA extraction using TRI Reagent LS (Molecular Research Center, 
Inc.) following the manufacturer’s protocol. Purified RNAs were further 
treated with DNase (TURBO DNase kit; Ambion) following the manufactur-
er’s protocol and used for reverse transcription (SuperScript III kit obtained 
from Invitrogen) with oligo dT primer. The reverse-transcribed cDNAs were 
then treated with RNase H (Invitrogen) for 30 min at 37°C and used for PCR 
with Kv1.1-specific primers (see Primers used section).
HuD overexpression in cultured neurons
Cultured hippocampal neurons were transfected at DIV 12 with cDNAs cod-
ing for myc-tagged HuD or pCDNA3 with EGFP. 48 h after transfection, 
neurons were treated with 50 µM DMSO or cycloheximide for 4 h, fixed, 
and immunostained with Kv1.1- or Kv4.2-specific antibodies (NeuroMab).
GST pull-down
Neurons were treated at DIV 21 with 200 nM rapamycin or DMSO for 
75 min at 37°C in aCSF. Neuronal lysates were isolated in Hepes-based 
buffer and homogenized. Nuclei and unbroken cells were removed by low 
speed centrifugation (900 rpm at 10 min), and supernatant was trans-
ferred to a new tube containing TRI Reagent LS. RNA was isolated follow-
ing the manufacturer’s instructions (Molecular Research Center, Inc.). 500 ng 
GST or GST-HuD was incubated with 2.25 µg RNA for 45 min at RT in 
binding buffer (20 mM Hepes, pH 7.9, 3 mM magnesium acetate, 50 mM 
potassium acetate, 0.2 µg/µl yeast tRNA, TCEP, RNaseOUT, and 5% glyc-
erol). Protein agarose A/G beads (Santa Cruz Biotechnology, Inc.) were 
precoated with rabbit pan-Hu antibody in binding buffer or rabbit IgG 
(Santa Cruz Biotechnology, Inc.) in binding buffer without the yeast tRNA, 
TCEP, RNaseOUT, and glycerol for 2 h at RT. 50 µl of the precoated IgG 
beads were used to preclear GST/RNA in solution for 1 h at RT. IgG beads 
For detection of Kv1.1 mRNA pulled downed by HuD, we used 
Kv1.1 FL and miR-129 forward primer, 5-GCCGCCGCAGCTCCTCTAC-
TATCAG-3, and reverse primer, 5-GCTTTTGATTGCTTGCCTGGTGCTT-3; 
Kv1.1 CR forward primer, 5-GGCCATCCTCAGGGTCATCCGCTTG-3, and 
reverse primer, 5-ACACCACCGCCCACCAGAAAGCATC-3; CaMKII 
forward primer, 5-CCCTTGGATGTTGCTGGAATTCTC-3, and reverse 
primer, 5-GGGTGGGTCAACACTGGAGACAAAC-3; GAP-43 forward 
primer, 5-GGAATAAGGATCCGAGGAGGAAAGG-3, and reverse primer, 
5-CTTAAAGTTCAGGCATGTTCTTGGT-3; GAPDH forward primer, 
5-GCAAGAGAGAGGCCCTCAG-3, and reverse primer, 5-TGTGAGGG-
AGATGCTCAGTG-3; and Homer1a forward primer, 5-TGGGTGTCTG-
GAGTTCTTCCCTTT-3, and reverse primer, 5-ATGAAGACCCATCTGC-
CACGATCA-3 (adapted from Tiruchinapalli et al., 2008).
LNA transfection of cultured neurons
DIV12 neurons were transfected using Lipofectamine 2000. For each 
well, 0.4 µg EGFP DNA and 100 nM LNA (either the scrambled or miR-
129–specific probes obtained from Exiqon) were used for transfection in 
a 1:5 dilution with Neurobasal medium. Neurons were incubated with 
the transfection mix for 2 h at 37°C and returned to conditioned media 
afterward. 24 h after transfection, neurons were fixed, permeabilized, and 
immunostained with Kv1.1 antibody as described in the Immunofluores-
cence and image analysis section. Signal quantitated by blindly choosing 
EGFP-positive neurons. Fluorescent images of EGFP-transfected neurons 
and Kv1.1 signals were then taken as outlined in the Immunofluorescence 
and image analysis section.
miR-129 overexpression assay
Cultured hippocampal neurons were transduced with control or miR-129-2 
precursor lentivirus (3 × 105 IU; Biosettia) at DIV 14. Neurons were treated 
at DIV 21 for 75 min with DMSO or rapamycin. miR-129–overexpressing 
neurons were detected by immunostaining for DsRed. Kv1.1 surface pro-
tein was detected by using an antibody that detects an extracellular do-
main of Kv1.1 (NeuroMab) using nonpermeabilized neurons.
Northern blot analysis
4 µg of total RNA from DMSO- or rapamycin-treated cells or 2.5 µg of total 
RNA from scrambled or LNA-transfected cells was separated on a Tris- 
borate-EDTA-urea-15% polyacrylamide gel. The gel was transferred onto a 
piece of membrane (Hybond N+; GE Healthcare). The blot was UV cross-
linked using a cross-linking system (HL-200 HybriLinker; UVP). The blot was 
probed for hsa-miR-129-5p miRNA as previously described (Grundhoff et 
al., 2006). The blot was stripped with boiling hot stripping buffer (0.1% so-
dium dodecyl sulfate [Sigma-Aldrich] in double-distilled water) and then 
probed for hsa-let-7a. The sequences for the probes used were as follows: 
hsa-miR-129-5p, 5-GCAAGCCCAGACCGCAAAAAG-3; and hsa-let-7a-
5p, 5-AACTATACAACCTACTACCTCA-3. Quantitative values for the 
Northern blot analysis were obtained using the Quantity One Analysis Soft-
ware (Bio-Rad Laboratories; Grundhoff et al., 2006).
Local translation assay
Local translation assay was performed essentially as reported by Raab- 
Graham et al. (2006) with the following modifications: primary culture of neu-
rons (DIV 14–28) infected with Sindbis virus coding for Kaede-Kv1.1 FL or 
Kaede-Kv1.1 miR-129 for 18–24 h were placed in a 35-mm dish containing 
Hepes-based aCSF with either 200 nM DMSO or rapamycin and immedi-
ately imaged (before photoconversion). Confocal excitation imaging was ac-
complished using an upright microscope (SP5) with a water immersion lens 
(HCX Apochromat L20×/0.05 NA water UV to infrared) at RT. A 488-nm 
laser was used to excite Kaede-Kv1.1, and green emission was detected at 
498–534 nm. Serial 1.0-µm z sections of a neuron expressing Kaede-Kv1.1 
were acquired and then photoconverted using a DAPI filter for 30 s. After the 
initial photoconversion, the final image was acquired at 120 min after pho-
toconversion. Maximum projected images from z-compressed stacks were 
used for data analysis using SP5 software. For each neuron, the mean inten-
sity of 8–10 puncta >60 µm from the soma was measured. All images were 
analyzed blindly using photoconverted protein as an unbiased selection of 
puncta. The magnitude of new protein synthesis was calculated by determin-
ing the fold increase of the mean green pixel intensity of puncta 120 min 
after photoconversion (F) as compared with that immediately after photocon-
version (F0; time point 0) and calculated using the equation F/F = (F  F0)/F0. 
Mean basal translation under control conditions (Kaede-Kv1.1 FL with 
DMSO) was set equal to 100%, and relative new translations measured with 
rapamycin or Kaede-Kv1.1 miR-129 ± rapamycin are reported as a per-
cent increase over the mean basal translation.
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were removed by centrifugation, and the supernatant was added to pre-
coated rabbit anti-HuD beads and incubated for 2 h at RT. Beads were 
washed with diluted binding buffer (0.5×) without glycerol six times and 
then eluted with TRI reagent following the manufacturer’s protocol (the 
Direct-zol RNA minikit; Zymo Research). Isolated RNA was treated with 
DNase I (TURBO DNase kit) and reverse transcribed using the cDNA synthe-
sis kit (iScript; Bio-Rad Laboratories) following the manufacturer’s protocol. 
cDNA was treated with RNase H and subjected to PCR using Kv1.1-, 
GAP43-, and CaMKII-specific primers (see Primers used section). PCR was 
performed using the SYBR green kit (iQ; Bio-Rad Laboratories). PCR was ter-
minated between cycles 25 and 30 to prevent saturation.
mRNA degradation assay
mRNA degradation assay was performed essentially as previously de-
scribed (Origanti et al., 2012). In brief, DIV 21 cultured cortical neurons 
were treated with 12 µM actinomycin for 4 h before the addition of 200 nM 
rapamycin. Neurons were treated with rapamycin or DMSO plus actinomy-
cin for 75 min in Hepes-based aCSF at 37°C. Neurons were harvested in 
Hepes-based buffer containing TCEP and RNaseOUT and homogenized. 
After a low speed centrifugation (900 rpm at 10 min), the supernatant was 
removed to a new tube containing TRI Reagent LS. RNA was isolated fol-
lowing the manufacturer’s instructions (Applied Biosystems). Total RNA was 
treated with DNase, quantitated, and subjected to RT-qPCR using CaMKII-
specific primers as outlined under the qPCR for mRNA or miRNA section. 
Degradation was measured as the percent remaining after treatment with 
rapamycin as compared with DMSO-treated neurons.
Online supplemental material
Fig. S1, related to Fig. 1 and Fig. 2, shows posttranscriptional regulation of 
Kv1.1 mRNA mediated by mTRS in the 3UTR of Kv1.1. Fig. S2 is related 
to Fig. 3 and displays a schematic representation of the pull-down assay to 
determine miR-129 binding to Kv1.1, LNA KD of miR-129 in neurons, and 
cell body analysis of neurons overexpressing miR-129. Fig. S3, related to 
Fig. 5, includes the quantification of in situ hybridization and EGFP signal 
between control and neurons expressing Kv1.1 miR-129. Fig. S4, related 
to Fig. 6 and Fig. 7, displays the predicted low affinity HuD binding sites 
present in the CR of Kv1.1 mRNA and that HuD binding to EGFP-CaMKII 
UTR results in increased EGFP levels. Fig. S5 indicates the model supported 
by the data presented in this paper for the bidirectional regulation of Kv1.1 
mRNA translation. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.201212089/DC1.
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